CNY 9.21
(-0.97%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.64 Million | 32.91 Million | -19.12 Million | 20.88 Million | 25.11 Million | 24.79 Million |
Net Income | -25.17 Million | -32.68 Million | -9.66 Million | 4.02 Million | 8.9 Million | -156.4 Million |
Depreciation & Amortization | 31.77 Million | 31.85 Million | 32.01 Million | 33.56 Million | 33.66 Million | 31.6 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -15.14 Million | 30.26 Million | -45.13 Million | -24.38 Million | -15.49 Million | 8.82 Million |
Other non-cash items | 84.58 Million | 3.48 Million | 3.66 Million | 7.67 Million | -1.95 Million | 140.76 Million |
Investing Cash Flow | -1.59 Million | -1.91 Million | -10.49 Million | 2.88 Million | -4.27 Million | -15.92 Million |
Investments in PPE | -1.64 Million | -1.91 Million | -10.8 Million | -4 Million | -7.98 Million | -15.92 Million |
Acquisitions | 45.5 Thousand | - | 306.24 Thousand | 233.2 Thousand | 3.71 Million | 500.00 |
Investment purchases | - | - | - | -233.2 Thousand | - | - |
Sales/Maturities of investments | - | - | - | 6.65 Million | - | - |
Other Investing Activities | 45.5 Thousand | - | 0.09 | 233.2 Thousand | 0.90 | 500.00 |
Financing Cash Flow | - | -2.48 Million | - | -2 Million | 2 Million | 4.33 Million |
Debt repayment | - | - | - | -2 Million | -2 Million | -5 Million |
Dividends payments | - | - | - | - | - | -663.81 Thousand |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -2.48 Million | - | -2 Million | 2 Million | 5 Million |
Accounts receivables | 3.51 Million | 23.04 Million | -29.28 Million | -11.8 Million | -7.93 Million | -41.27 Million |
Accounts payables | -13.6 Million | -10.84 Million | 19.15 Million | 4.04 Million | -14.85 Million | 30.64 Million |
Inventory | -5.05 Million | 18.07 Million | -35 Million | -16.62 Million | 7.29 Million | 19.45 Million |
Other working capital | -13.6 Million | - | 0.27 | -0.72 | 0.09 | -10.62 Million |
Cash at beginning of period | 69.76 Million | 39.37 Million | 68.99 Million | 47.22 Million | 24.38 Million | 11.17 Million |
Cash at end of period | 65.53 Million | 67.88 Million | 39.37 Million | 68.99 Million | 47.22 Million | 24.38 Million |
Capital Expenditure | -1.64 Million | -1.91 Million | -10.8 Million | -4 Million | -7.98 Million | -15.92 Million |
Effect of forex changes on cash | - | -0.19 | - | - | -0.48 | - |
Net cash flow / Change in cash | -4.22 Million | 28.51 Million | -29.62 Million | 21.76 Million | 22.84 Million | 13.21 Million |
Free Cash Flow | -4.28 Million | 31 Million | -29.92 Million | 16.87 Million | 17.13 Million | 8.87 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | -6.06 Million | -6.85 Million | -25.17 Million | -11.79 Million | -3.37 Million |
Depreciation & Amortization | - | 7.39 Million | 7.39 Million | 31.77 Million | 7.87 Million | -15.94 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -15.14 Million | -1.54 Million | 35.03 Million |
Other non-cash items | - | 16.72 Million | -26.32 Million | 84.58 Million | 56.13 Million | -12.47 Million |
Investing Cash Flow | -565.27 Thousand | -75.92 Thousand | -797.56 Thousand | -1.59 Million | -980.1 Thousand | -401.03 Thousand |
Investments in PPE | -565.27 Thousand | -75.92 Thousand | -805.56 Thousand | -1.64 Million | -1.01 Million | -401.03 Thousand |
Acquisitions | - | - | 8000.00 | 45.5 Thousand | 34 Thousand | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 8000.00 | 45.5 Thousand | 34 Thousand | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | 3.51 Million | 3.51 Million | 32.62 Million |
Accounts payables | - | - | - | -13.6 Million | - | - |
Inventory | - | - | - | -5.05 Million | -5.05 Million | 2.41 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 32.84 Million | 31.55 Million | 65.53 Million | 69.76 Million | 30.03 Million | 25.31 Million |
Cash at end of period | 51.51 Million | 34.73 Million | 31.55 Million | 65.53 Million | 65.53 Million | 28.15 Million |
Capital Expenditure | -565.27 Thousand | -75.92 Thousand | -805.56 Thousand | -1.64 Million | -1.01 Million | -401.03 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 18.67 Million | 3.17 Million | -33.98 Million | -4.22 Million | 35.5 Million | 2.84 Million |
Free Cash Flow | -565.27 Thousand | 3.17 Million | -33.98 Million | -4.28 Million | 35.45 Million | 2.84 Million |
VLTSA
CIR
TFG
300808
2587
ALKEM